Ajami Ghloamhossein, Derakhshan Ali, Amoozgar Hamid, Mohamadi Mohammad, Borzouee Mohammad, Basiratnia Mitra, Abtahi Saeid, Cheriki Sirous, Soltani Manochehr
Divisions of Pediatric Cardiology and Pediatric Nephrology, Department of Pediatrics, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Pediatr Cardiol. 2010 Jul;31(5):668-73. doi: 10.1007/s00246-010-9680-2. Epub 2010 Feb 27.
Despite increasing reports on nonionic contrast media-induced nephropathy (CIN) in hospitalized adult patients during cardiac procedures, the studies in pediatrics are limited, with even less focus on possible predisposing factors and preventive measures for patients undergoing cardiac angiography. This prospective study determined the incidence of CIN for two nonionic contrast media (CM), iopromide and iohexol, among 80 patients younger than 18 years and compared the rates for this complication in relation to the type and dosage of CM and the presence of cyanosis. The 80 patients in the study consecutively received either iopromide (group A, n = 40) or iohexol (group B, n = 40). Serum sodium (Na), potassium (K), and creatinine (Cr) were measured 24 h before angiography as baseline values, then measured again at 12-, 24-, and 48-h intervals after CM use. Urine samples for Na and Cr also were checked at the same intervals. Risk of renal failure, Injury to the kidney, Failure of kidney function, Loss of kidney function, and End-stage renal damage (RIFLE criteria) were used to define CIN and its incidence in the study population. Accordingly, among the 15 CIN patients (18.75%), 7.5% of the patients in group A had increased risk and 3.75% had renal injury, whereas 5% of group B had increased risk and 2.5% had renal injury. Whereas 33.3% of the patients with CIN were among those who received the proper dosage of CM, the percentage increased to 66.6% among those who received larger doses, with a significant difference in the incidence of CIN related to the different dosages of CM (p = 0.014). Among the 15 patients with CIN, 6 had cyanotic congenital heart diseases, but the incidence did not differ significantly from that for the noncyanotic patients (p = 0.243). Although clinically silent, CIN is not rare in pediatrics. The incidence depends on dosage but not on the type of consumed nonionic CM, nor on the presence of cyanosis, and although CIN usually is reversible, more concern is needed for the prevention of such a complication in children.
尽管有关住院成年患者在心脏手术期间发生非离子型造影剂所致肾病(CIN)的报道日益增多,但儿科方面的研究却很有限,对于接受心脏血管造影术的患者,可能的易感因素和预防措施的关注更是少之又少。这项前瞻性研究确定了两种非离子型造影剂(CM)——碘普罗胺和碘海醇——在80名18岁以下患者中的CIN发生率,并比较了该并发症发生率与CM类型、剂量以及发绀情况之间的关系。研究中的80名患者连续接受了碘普罗胺(A组,n = 40)或碘海醇(B组,n = 40)。在血管造影术前24小时测量血清钠(Na)、钾(K)和肌酐(Cr)作为基线值,在使用CM后的12小时、24小时和48小时间隔再次测量。同时在相同间隔检查尿样中的Na和Cr。采用肾衰竭、肾损伤、肾功能衰竭、肾功能丧失和终末期肾损害(RIFLE标准)来定义CIN及其在研究人群中的发生率。因此,在15例CIN患者(18.75%)中,A组7.5%的患者风险增加,3.75%的患者有肾损伤,而B组5%的患者风险增加,2.5%的患者有肾损伤。CIN患者中33.3%属于接受适当剂量CM的患者,而接受较大剂量CM的患者中这一比例增至66.6%,CIN发生率与不同剂量的CM存在显著差异(p = 0.014)。在15例CIN患者中,6例患有青紫型先天性心脏病,但其发生率与非青紫型患者相比无显著差异(p = 0.243)。尽管在临床上无明显症状,但CIN在儿科并不罕见。其发生率取决于剂量,而非所使用的非离子型CM的类型,也与发绀情况无关,并且尽管CIN通常是可逆的,但在儿童中预防此类并发症仍需要更多关注。